Answers from every biopsy
QuantumCyte is a Fremont, California-based biotechnology company pioneering next-generation automated microdissection pathology through its Cytomask platform. The company combines patented science and technology to link digital pathology with molecular analysis, enabling high-precision tissue analysis from biopsy samples. QuantumCyte has collaborated with Roche on molecular pathology applications for precision medicine.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2023
Feb 2022
Jun 2021
Jun 2019
Jun 2018
May 2017
Create a free account to see which investors have funded this company.
Create Free Account
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
